ArticleInternational journal of cancer2022

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry.

Marissa Meegdes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.